Table 5

Total Value of vaccination sensitivity analysis results (2019 US$)

Total VoCV2.5th Percentile97.5th Percentile
Probabilistic sensitivity analysis
 All vaccinesUS$5.2TUS$4.1TUS$6.2T
  % different from total VoCV−21.3%21.2%
 Pfizer-BioNTechUS$1.9TUS$1.5TUS$2.3T
  % different from total VoCV−21.2%20.5%
One-way sensitivity analyses
IHME lower bound infections
 All vaccinesUS$4.1T
  % different from total VoCV−20.6%
 Pfizer-BioNTechUS$1.5T
  % different from total VoCV−20.1%
IHME upper bound infections
 All vaccinesUS$6.3T
  % different from total VoCV21.8%
 Pfizer-BioNTechUS$2.3T
  % different from total VoCV22.3%
IHME unscaled deaths
 All vaccinesUS$4.2T
  % different from total VoCV−18.2%
 Pfizer-BioNTechUS$1.5T
  % different from total VoCV−20.7%
0% discount rate
 All vaccinesUS$5.8T
  % different from total VoCV13.3%
 Pfizer-BioNTechUS$2.2T
  % different from total VoCV14.3%
6% discount rate
 All vaccinesUS$4.8T
  % different from total VoCV−7.2%
 Pfizer-BioNTechUS$1.8T
  % different from total VoCV−7.9%
  • IHME, Institute for Health Metrics and Evaluation; T, trillion; VoCV, value of COVID-19 vaccination.